Targeting Protein Kinases in Cancer


A General Allele-Specific Model for Understanding and Treating Tumors Driven by ERK-Activation


High Dose Vitamin C and Inactivation of DNA Repair Boost Cancer Immunotherapy


Short Talk: Regulation of PTEN Translation by PI3K Signaling Maintains Pathway Homeostasis


Short Talk: Oncogenic CCNE1 Amplification Is Synthetic Lethal with PKMYT1 Kinase Inhibition


Coffee Break


Informing Patient Treatment with Clinicogenomic Data


The Future of Precision Oncology


NCI’s Precision Medicines Initiatives


Closing Remarks